Abstract
ObjectiveTo describe changes in immune parameters observed during long-term methotrexate (MTX) therapy in patients with active rheumatoid arthritis (RA) and explore correlations with simultaneously measured MTX pharmacokinetic (PKC) parameters.DesignProspective, open-label,...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have